| iSpeciman is a technology-driven company engaged in life science research and development via a single global marketplace platform that connects researchers to subjects, specimens, and associated data. Co.'s technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, Co. handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The ISPC average annual return since 2021 is shown above.
The Average Annual Return on the ISPC average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether ISPC average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ISPC average annual return calculation with any dividends reinvested as applicable (on ex-dates).